Pardini Matteo, Krueger Frank, Hodgkinson Colin A, Raymont Vanessa, Strenziok Maren, Amore Mario, Wassermann Eric M, Goldman David, Grafman Jordan H
1Department of Neurosciences,Rehabilitation,Ophthalmology,Genetics and Maternal and Child Health,University of Genoa,Genoa,Italy.
3Molecular Neuroscience Department,George Mason University,Fairfax,Virginia,USA.
CNS Spectr. 2014 Oct;19(5):382-90. doi: 10.1017/S1092852914000108. Epub 2014 Mar 11.
This study evaluated whether structural brain lesions modulate the relationship between pathological aggression and the dopaminergic system in traumatic brain injury (TBI). While converging evidence suggests that different areas of the prefrontal cortex modulate dopaminergic activity, to date no evidence exists of a modulation of endogenous dopaminergic tone by lesion localization in penetrating TBI (pTBI).
This study included 141 male Caucasian veterans who suffered penetrating pTBI during their service in Vietnam and 29 healthy male Caucasian Vietnam veterans. Participants were genotyped for 3 functional single nucleotide polymorphisms (SNPs): dopamine receptor D1 (DRD1) rs686, dopamine receptor D2 (DRD2) rs4648317, and catechol-O-methyltransferase (COMT) Val158Met. Patients underwent brain CT scans and were divided into medial prefrontal cortex, lateral prefrontal cortex, and posterior cortex lesion groups. Long-term aggression levels were evaluated with the agitation/aggression subscale of the Neuropsychiatric Inventory.
Our data showed that carriers of more transcriptionally active DRD1 alleles compared to noncarriers demonstrated greater aggression levels due to medial prefrontal cortex lesions but reduced aggression levels due to lateral prefrontal cortex lesions independently of DRD2 rs4648317 or COMT Val158Met genotypes.
Our results suggest that the relationship between pTBI-related aggression and the dopaminergic system is modulated by lesion location. Potentially lesion location could represent an easy-to-use, widely available, para-clinical marker to help in the development of an individualized therapeutic approach to pTBI-related pathological aggression.
本研究评估了脑结构损伤是否会调节创伤性脑损伤(TBI)中病理性攻击行为与多巴胺能系统之间的关系。尽管越来越多的证据表明前额叶皮质的不同区域会调节多巴胺能活动,但迄今为止,尚无证据表明穿透性TBI(pTBI)中的损伤定位会对内源性多巴胺能张力产生调节作用。
本研究纳入了141名在越南服役期间遭受穿透性pTBI的白人男性退伍军人以及29名健康的白人男性越南退伍军人。对参与者进行了3种功能性单核苷酸多态性(SNP)的基因分型:多巴胺受体D1(DRD1)rs686、多巴胺受体D2(DRD2)rs4648317和儿茶酚-O-甲基转移酶(COMT)Val158Met。患者接受脑部CT扫描,并被分为内侧前额叶皮质、外侧前额叶皮质和后皮质损伤组。使用神经精神科问卷的激越/攻击分量表评估长期攻击水平。
我们的数据显示,与非携带者相比,携带转录活性更高的DRD1等位基因的个体,由于内侧前额叶皮质损伤,攻击水平更高,但由于外侧前额叶皮质损伤,攻击水平降低,这与DRD2 rs4648317或COMT Val158Met基因型无关。
我们的结果表明,pTBI相关攻击行为与多巴胺能系统之间的关系受损伤位置的调节。潜在地,损伤位置可能是一种易于使用、广泛可用的辅助临床标志物,有助于制定针对pTBI相关病理性攻击行为的个体化治疗方法。